Game plan for the day and the weeks ahead, plus a second, lower-volatility way to get exposure.
Priced above the range, perps well above that
Anthropic (ANT) priced at $83, above the high end of the expected $70 to $78 range. At 8:45 a.m. ET, ANT perpetual futures were trading at $104, about 25% over the IPO price.
We have seen this movie recently. Into the SpaceX (SPCX) IPO, the perps traded around $170, roughly $45 above the IPO price, only to be sold aggressively into the low $150s before public trading started.
As of this morning, you know whether you got an allocation. From what I am hearing from friends, at least through Fidelity, allocations ran maybe 20% of requested size, though those who asked for a small allotment (25 shares) got the full amount. Why does that matter? Some holders may hedge by shorting the perps and locking in the spread between the $83 IPO price and $104, a roughly 25% “risk-free” return that also sidesteps the flipping rules some platforms enforce. Expect the perps to trade lower into the ANT open, which is probably closer to 11:30 a.m. to 12:30 p.m. ET.
The IPO math: averages lie
A few big winners drag the average IPO return up, while the median IPO is down about 15.7% a year after its first open. Yikes. SpaceX is tracking below water too, down 8.4% from its first open after 109 trading days.

Why I like the tape around mega IPOs
This is one I put together on the average Invesco QQQ Trust (QQQ) return around the eight largest US-listed IPOs since 2000. The lead-in has seen more selling over the last two weeks, but that changes the setup coming out of the IPO. Much like my Nvidia (NVDA) preview note, this is a clearing event. I look for QQQ, which is up almost 2% overnight, to keep rallying into the weekend.

Day one: chase or wait?
If you did not get an allocation, the question is whether you want to chase the market higher. Because of my view on QQQ, I think ANT closes closer to its highs today, likely in the $115 to $120 area.
Another strategy: own it through Amazon
Volatility in ANT will be extremely high today. A different, lower-vol way to play it is Amazon (AMZN), which owns 14.7% of Anthropic. At $83, that stake is worth about $159 billion; at $115, it is worth roughly another $60 billion. With QQQ rallying in the background, passive flows into AMZN should pick up too.
Why ANT probably doesn’t run away to the upside
Final thought: I do not think ANT runs away to the topside, say above the $130 to $140 area, for two reasons.
- Many insiders can sell immediately.
- After reading the S-1, there is a chance, and I do not think it is coming today, that Anthropic raises more cash soon by selling additional equity. Wait, what? They just sold today. Yup, but they still need more money. If the stock rallies, they can sell more, as is their right under the filing. If they use that cash to fund some of their compute commitments, it would in theory also help the credit rating, which right now looks to be BB+: high yield, one notch below investment grade. Getting to investment grade would be a big deal, and it is likely the reason more equity gets sold, especially if the market gives Dario Amodei the opportunity.

Because of this feature, you may see profit taking into the closing print on a daily basis. Options are not listed yet, but once they are, selling calls against a long position on rips makes sense to me.
Wick's take: too much vol? Biotech is the AI winner
If this is too much volatility, or you do not like the valuation or the company, go back to the theme I first started this site writing about: biotech as the big winner from AI. Stanley Druckenmiller, one of the best portfolio managers of all time, has said the same thing: “probably the best use case out there of AI is biotech through drug discovery, diagnostics, monitoring everything.”
The relative strength of the SPDR S&P Biotech ETF (XBI) against the SPDR S&P 500 ETF Trust (SPY) is starting to turn.

Here is the first note on the theme, with a model portfolio allocation: Geopolitical tailwinds, the biotech theme and oil backwardation.
Off topic: college hoops
In men’s NCAA basketball, just 0.29% of players stay at the same school for four years. Sad.

And some interesting stats on the odds of going from high school to college sports, by division.


Comments